Evidence map›Paper›PMID 42540236›Full record

ArticleACS omega2026

Engineered Yolk-Shell Nanocarriers for Biphasic Release and Efficient Codelivery of Chemotherapy Drugs in Lung Cancer Cells.

Jiraporn Kamsarn, Ploydao Puangroglchana, Sarawut Kumphune, Nipon Theera-Umpon, Pathinan Paengnakorn, Hansoo Park, Phornsawat Baipaywad

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jiraporn KamsarnBiomedical Engineering Institute, CMU-BIOPOLIS Building, Chiang Mai University, Mae Hia Campus, Mueang Chiang Mai District, Chiang Mai 50100, Thailand.
Ploydao PuangroglchanaDepartment of Physics and Materials Science, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.
Sarawut KumphuneBiomedical Engineering Institute, CMU-BIOPOLIS Building, Chiang Mai University, Mae Hia Campus, Mueang Chiang Mai District, Chiang Mai 50100, Thailand.
Nipon Theera-UmponBiomedical Engineering Institute, CMU-BIOPOLIS Building, Chiang Mai University, Mae Hia Campus, Mueang Chiang Mai District, Chiang Mai 50100, Thailand.
Pathinan PaengnakornBiomedical Engineering Institute, CMU-BIOPOLIS Building, Chiang Mai University, Mae Hia Campus, Mueang Chiang Mai District, Chiang Mai 50100, Thailand.
Hansoo ParkDepartment of Integrative Engineering, Chung-Ang University, Korea, Seoul 06974, Republic of Korea.ORCID https://orcid.org/0000-0002-3125-7680
Phornsawat BaipaywadBiomedical Engineering Institute, CMU-BIOPOLIS Building, Chiang Mai University, Mae Hia Campus, Mueang Chiang Mai District, Chiang Mai 50100, Thailand.ORCID https://orcid.org/0000-0003-2549-410X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer is the leading cause of cancer-related deaths worldwide, with growing evidence suggesting that exposure to fine particulate matter (PM

Identifiers

PMID42540236
PMCPMC13425363

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.